KeyCorp reaffirmed their buy rating on shares of Teladoc (NYSE:TDOC) in a research report sent to investors on Monday. KeyCorp currently has a $39.00 target price on the health services provider’s stock.
A number of other research analysts have also commented on TDOC. BidaskClub raised Teladoc from a sell rating to a hold rating in a report on Wednesday, August 9th. Cowen reissued an outperform rating and set a $39.00 price target on shares of Teladoc in a report on Saturday, September 30th. Piper Jaffray Companies reissued a buy rating and set a $42.00 price target on shares of Teladoc in a report on Friday, September 29th. Cantor Fitzgerald reaffirmed a hold rating and set a $31.00 target price on shares of Teladoc in a research note on Tuesday, September 26th. Finally, Zacks Investment Research raised Teladoc from a sell rating to a hold rating in a research note on Thursday, September 21st. One research analyst has rated the stock with a sell rating, four have issued a hold rating and nine have given a buy rating to the company. The stock presently has a consensus rating of Buy and a consensus target price of $39.17.
Shares of Teladoc (NYSE:TDOC) opened at $31.50 on Monday. The company has a debt-to-equity ratio of 0.83, a current ratio of 5.08 and a quick ratio of 5.08. Teladoc has a 52-week low of $15.65 and a 52-week high of $37.90.
In related news, VP Mark Hirschhorn sold 25,000 shares of the stock in a transaction on Friday, September 22nd. The stock was sold at an average price of $31.93, for a total value of $798,250.00. Following the completion of the transaction, the vice president now owns 64,987 shares in the company, valued at approximately $2,075,034.91. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jason N. Gorevic sold 20,000 shares of the stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $32.10, for a total value of $642,000.00. Following the completion of the transaction, the chief executive officer now owns 838,261 shares of the company’s stock, valued at approximately $26,908,178.10. The disclosure for this sale can be found here. Insiders have sold 265,000 shares of company stock valued at $8,697,400 in the last ninety days. Company insiders own 4.47% of the company’s stock.
Several large investors have recently added to or reduced their stakes in the stock. Iguana Healthcare Management LLC acquired a new position in shares of Teladoc in the 3rd quarter valued at $1,160,000. Neuberger Berman Group LLC boosted its position in shares of Teladoc by 53.4% in the 3rd quarter. Neuberger Berman Group LLC now owns 25,785 shares of the health services provider’s stock valued at $855,000 after purchasing an additional 8,971 shares during the period. California Public Employees Retirement System boosted its position in shares of Teladoc by 52.1% in the 3rd quarter. California Public Employees Retirement System now owns 11,409 shares of the health services provider’s stock valued at $378,000 after purchasing an additional 3,909 shares during the period. Bamco Inc. NY boosted its position in shares of Teladoc by 751.9% in the 3rd quarter. Bamco Inc. NY now owns 1,455,900 shares of the health services provider’s stock valued at $48,263,000 after purchasing an additional 1,285,000 shares during the period. Finally, Granahan Investment Management Inc. MA purchased a new stake in Teladoc in the 3rd quarter worth about $14,569,000.
TRADEMARK VIOLATION WARNING: “KeyCorp Reaffirms Buy Rating for Teladoc (TDOC)” was first reported by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://www.tickerreport.com/banking-finance/3078946/keycorp-reaffirms-buy-rating-for-teladoc-tdoc.html.
Teladoc Company Profile
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Receive News & Ratings for Teladoc Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc and related companies with MarketBeat.com's FREE daily email newsletter.